How should I evaluate and manage a patient who vomits a dark‑red, clotted‑appearing material without obvious fresh blood?

Management of Dark Red Blood Clot Vomiting Without Fresh Blood

This presentation most likely represents upper gastrointestinal bleeding with altered blood ("coffee grounds"), and you must immediately assess hemodynamic stability, initiate resuscitation, and perform urgent upper endoscopy within 24 hours after stabilization.

---

Immediate Assessment & Resuscitation

Hemodynamic Evaluation

• Calculate the shock index (heart rate ÷ systolic blood pressure) immediately; a value >1 defines hemodynamic instability and mandates urgent intervention rather than routine endoscopy. 1
• Place two large-bore intravenous catheters in the antecubital fossae and begin aggressive crystalloid infusion (1–2 L of normal saline or Ringer's lactate) to restore blood pressure and heart rate. 2
• Insert a urinary catheter and monitor hourly urine output, targeting >30 mL/hour in patients with severe bleeding. 2
• Apply continuous automated blood pressure and heart rate monitoring for hemodynamically unstable patients. 2

Blood Transfusion Strategy

• Transfuse packed red blood cells when hemoglobin falls below 80 g/L (8 g/dL) in patients without cardiovascular disease. 2
• Use a higher hemoglobin threshold (≥80 g/L, targeting ≥100 g/L) for patients with underlying cardiovascular disease, hypertension, or ischemic heart disease. 1, 2
• Correct coagulopathy promptly: administer fresh-frozen plasma when INR >1.5 and platelet transfusion when platelet count <50 × 10⁹/L. 1

---

Risk Stratification

High-Risk Features Requiring ICU Admission

• Age >60 years is an independent high-risk factor. 2
• Shock (heart rate >100 bpm and systolic blood pressure <100 mmHg). 2
• Hemoglobin <100 g/L (10 g/dL) on admission. 2
• Major comorbidities: renal failure, liver failure, ischemic heart disease, heart failure, or disseminated malignancy. 2
• Vomiting red blood or red blood in nasogastric aspirate independently predicts rebleeding and adverse outcomes. 3

Glasgow Blatchford Score

• A Glasgow Blatchford Score ≤1 identifies very low-risk patients who can be managed as outpatients without hospitalization or urgent endoscopy. 2, 4
• Patients with any high-risk feature should be admitted to an intensive-care or monitored unit for at least 24–72 hours. 2

---

Pre-Endoscopic Pharmacologic Management

Proton Pump Inhibitor Therapy

• Initiate high-dose intravenous PPI therapy immediately upon presentation, before endoscopy: administer pantoprazole 80 mg IV bolus followed by continuous infusion of 8 mg/hour. 2
• High-dose IV PPI may downstage endoscopic lesions and reduce the need for endoscopic intervention, but it must not delay endoscopy. 2

Vasoactive Therapy (If Cirrhosis or Chronic Alcohol Use Suspected)

• If the patient has known or suspected liver cirrhosis, chronic alcohol use, or physical signs of chronic liver disease (ascites, spider angiomas, jaundice), presume variceal bleeding until proven otherwise. 2
• Start vasoactive therapy immediately: octreotide (50 µg IV bolus then 50 µg/hour infusion) or somatostatin (250 µg IV bolus then 250 µg/hour infusion). 2
• Administer antibiotic prophylaxis (ceftriaxone 1 g IV daily or norfloxacin 400 mg PO twice daily) to lower infection risk and reduce mortality. 2
• Continue both vasoactive agents and antibiotics for 3–5 days, regardless of initial endoscopy findings. 2

Avoid Routine Interventions

• Do not use promotility agents (e.g., erythromycin) routinely before endoscopy; they do not improve outcomes. 2
• Do not delay endoscopy in patients receiving anticoagulants (warfarin or direct oral anticoagulants). 2

---

Timing of Endoscopy

Standard Timing

• Perform diagnostic upper endoscopy within 24 hours of presentation for all hospitalized patients after initial hemodynamic stabilization. 2, 4

Urgent Endoscopy (Within 12 Hours)

• For high-risk patients with ongoing hemodynamic instability (shock index ≥1), altered mental status, or suspected variceal bleeding, perform urgent upper endoscopy within 12 hours after airway protection and initial resuscitation. 2

Airway Protection

• In patients with severe hypoxemia (oxygen saturation ≈85%) and altered mental status, perform immediate endotracheal intubation before any endoscopic procedure to protect the airway and prevent massive aspiration. 2

---

Endoscopic Hemostatic Therapy

High-Risk Stigmata (Active Bleeding or Visible Vessel)

• Use combination therapy: epinephrine injection plus a second modality (thermal coagulation, sclerosant injection, or through-the-scope clips). 2, 4
• Epinephrine injection alone is insufficient and must never be used as sole therapy. 2, 4

Adherent Clots

• Perform targeted irrigation to attempt clot dislodgement, followed by appropriate definitive treatment of the underlying lesion. 2

Low-Risk Stigmata

• Endoscopic hemostatic therapy is not indicated for low-risk stigmata such as clean-based ulcers or flat pigmented spots. 2

---

Post-Endoscopic Management

High-Dose PPI Continuation

• After successful endoscopic therapy for high-risk stigmata, continue intravenous pantoprazole at 8 mg/hour for exactly 72 hours. 2
• After 72 hours, switch to oral PPI twice daily for 14 days, then once daily thereafter (duration adjusted to underlying cause). 2

Monitoring

• Maintain the patient in a monitored setting for at least 72 hours following endoscopic therapy. 2

---

Management of Rebleeding

Repeat Endoscopy

• If clinical evidence of rebleeding appears (fresh hematemesis, melena, or hemodynamic deterioration), repeat endoscopy is the first-line salvage strategy. 2

CT Angiography

• When repeat endoscopy fails, obtain CT angiography to localize the bleeding source; this imaging modality has a sensitivity of 79–95% and specificity of 95–100%. 2

Angiographic Embolization

• Visceral angiography with embolization is indicated for endoscopically refractory bleeding, achieving a diagnostic and therapeutic success rate of 88–100%. 2

Surgery

• Surgical intervention is reserved for patients who do not respond to both endoscopic and angiographic therapies. 2

---

Helicobacter pylori Testing

• All patients presenting with peptic ulcer bleeding should be tested for H. pylori and, if positive, receive eradication therapy. 2
• Testing performed during acute bleeding may yield false-negative results; a confirmatory test after the acute phase is advisable. 2

---

Critical Pitfalls to Avoid

• Do not postpone intubation in severely hypoxemic, mentally altered patients; airway protection is the top priority. 2
• Endoscopy must not be undertaken before adequate hemodynamic stabilization and airway protection. 2
• Do not rely on epinephrine injection alone for endoscopic hemostasis; its efficacy is suboptimal when used in isolation. 2, 4
• Do not assume that dark red blood clots always indicate a lower GI source; up to 10–15% of severe hematochezia originates from the upper gastrointestinal tract. 1
• Do not delay resuscitation to obtain imaging; hemodynamic stabilization must occur before any diagnostic procedure. 2